John M. Lasala, MD, PhD, FACC, MSCAI

Professor of Medicine

Additional Titles

  • Director, Structural Heart Disease

Related Links


  • BA: Drew University, Madison, NJ (1975)
  • Postdoctoral Fellow, Anatomy and Neurobiology: Washington University School of Medicine, St. Louis, MO (1979)
  • PhD: St. Louis University, St. Louis, MO (1979)
  • MD: University of Connecticut, Farmington, CT (1983)
  • Intern and Resident, Medicine: Barnes-Jewish Hospital, Washington University School of Medicine, St. Louis , MO (1986)
  • Fellowship, Cardiology: Yale University School of Medicine, New Haven, CT (1989)
  • Fellowship, Interventional Cardiology: Yale University School of Medicine, New Haven, CT (1990)

Board Certifications

  • Cardiovascular Diseases
  • Interventional Cardiology


  • Master Interventionalist of SCAI, 2017
  • American Heart Association: Hugh McCulloch Award Recipient, 2011
  • Brien McMahon High School Hall of Fame, 2009
  • Best Doctors in America, 2007-2016
  • Best Doctors in St. Louis, 2007-2016
  • Board of Trustees: The Society for Angiography and Interventions, 2004
  • Magnetically Navigable and/or Controllable Device for Removing Material from Body Lumens and Cavities. Stereotaxis, Inc. Patented August 6, 2002.
  • Outstanding Cardiology Alumnus Award, 2000
  • Yale University School of Medicine, 2000
  • American Heart Association Research Fellowship, 1988
  • Co-Chairman-Society: Cardiac Angiography & Interventional (SCAI) Meeting, 1998
  • March of Dimes, Medical Student Research Grant, 1980
  • Teaching Assistant St. Louis University School of Medicine, Department of Biochemistry, 1978
  • Honors in Chemistry, Drew University, 1975
  • New Jersey American Chemical Society Undergraduate, Research Award, Co-Winner, 1975
  • National Football Foundation and Hall of Fame Scholar-Athlete Award, 1971

Clinical Interests

Complex coronary intervention, hemodynamics support, structural heart disease including mitral, aortic, and adult congenital

Research Interests

Cardiac Catheterizations, coronary artery disease, percutaneous transluminal coronary angioplasty (PTCA), myocardial infarction, coronary-artery stenting, structural heart disease. The treatment of rheumatic mitral stenosis, percutaneous repair of mitral regurgitation and percutaneous replacement of aortic valve for aortic stenosis, percutaneous repair of congenital defects and ASD, PFO, VSD and PDA.


View publications on